Skip to main content
Top
Published in: Archives of Virology 11/2013

01-11-2013 | Brief Report

Oseltamivir-resistant influenza viruses isolated in South Korea from 2005 to 2010

Authors: Han-Gil Cho, Jang-Hoon Choi, Hyun-Kyung Lee, Su-Kyoung Mun, Jong-Bok Lee, Eek-Hoon Jho, Chun Kang, Young-Hee Lim

Published in: Archives of Virology | Issue 11/2013

Login to get access

Abstract

South Korean isolates of oseltamivir-resistant influenza viruses from 2005–2010 were investigated with a total 491 influenza viruses identified from 1702 specimens. Neuraminidase genes from 342 influenza viruses (71 A/H1N1, 74 pandemic A/H1N1 2009, 117 A/H3N2, and 80 B) were analyzed by RT-PCR with molecular markers for oseltamivir resistance. The H274Y mutation in the NA protein was identified in 100 % (n=40) of A/H1N1 viruses circulating in 2008–2009. Influenza A/H1N1 viruses harboring the H274Y substitution exhibited, on average, a 626-fold reduction in oseltamivir susceptibility and clustered with the A/Norway/1736/2007 strain. Close and timely monitoring for resistance to clinically available influenza antivirals should be consistently performed.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cox NJ, Subbarao K (2000) Global epidemiology of influenza: past and present. Annu Rev Med 51:407–421PubMedCrossRef Cox NJ, Subbarao K (2000) Global epidemiology of influenza: past and present. Annu Rev Med 51:407–421PubMedCrossRef
2.
go back to reference Xu X, Subbarao K, Cox NJ, Guo Y (1999) Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong. Virology 261:15–19PubMedCrossRef Xu X, Subbarao K, Cox NJ, Guo Y (1999) Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong. Virology 261:15–19PubMedCrossRef
3.
go back to reference Garten RJ, Davis CT, Russell CA et al (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325:197–201PubMedCrossRef Garten RJ, Davis CT, Russell CA et al (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325:197–201PubMedCrossRef
4.
go back to reference Lackenby A, Thompson CI, Democratis J (2008) The potential impact of neuraminidase inhibitor resistant influenza. Curr Opin Infect Dis 21:626–638PubMedCrossRef Lackenby A, Thompson CI, Democratis J (2008) The potential impact of neuraminidase inhibitor resistant influenza. Curr Opin Infect Dis 21:626–638PubMedCrossRef
5.
go back to reference Bright RA, Medina MJ, Xu X, Perez-Oronoz G, Wallis TR, Davis XM, Povinelli L, Cox NJ, Klimov AI (2005) Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 366:1175–1181PubMedCrossRef Bright RA, Medina MJ, Xu X, Perez-Oronoz G, Wallis TR, Davis XM, Povinelli L, Cox NJ, Klimov AI (2005) Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 366:1175–1181PubMedCrossRef
7.
go back to reference Sheu TG, Deyde VM, Okomo-Adhiambo M, Garten RJ, Xu X, Bright RA, Butler EN, Wallis TR, Klimov AI, Gubareva LV (2008) Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob Agents Chemother 52:3284–3292PubMedCrossRef Sheu TG, Deyde VM, Okomo-Adhiambo M, Garten RJ, Xu X, Bright RA, Butler EN, Wallis TR, Klimov AI, Gubareva LV (2008) Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob Agents Chemother 52:3284–3292PubMedCrossRef
8.
go back to reference Hauge SH, Dudman S, Borgen K, Lackenby A, Hungnes O (2009) Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007–08. Emerg Infect Dis 15:155–162PubMedCrossRef Hauge SH, Dudman S, Borgen K, Lackenby A, Hungnes O (2009) Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007–08. Emerg Infect Dis 15:155–162PubMedCrossRef
9.
go back to reference Hurt AC, Ernest J, Deng YM, Iannello P, Besselaar TG, Birch C, Buchy P, Chittaganpitch M, Chiu SC, Dwyer D, Guigon A, Harrower B, Kei IP, Kok T, Lin C, McPhie K, Mohd A, Olveda R, Panayotou T, Rawlinson W, Scott L, Smith D, D’Souza H, Komadina N, Shaw R, Kelso A, Barr IG (2009) Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. Antiviral Res 83:90–93PubMedCrossRef Hurt AC, Ernest J, Deng YM, Iannello P, Besselaar TG, Birch C, Buchy P, Chittaganpitch M, Chiu SC, Dwyer D, Guigon A, Harrower B, Kei IP, Kok T, Lin C, McPhie K, Mohd A, Olveda R, Panayotou T, Rawlinson W, Scott L, Smith D, D’Souza H, Komadina N, Shaw R, Kelso A, Barr IG (2009) Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. Antiviral Res 83:90–93PubMedCrossRef
10.
go back to reference Baranovich T, Saito R, Suzuki Y, Zaraket H, Dapat C, Caperig-Dapat I, Oguma T, Shabana II, Saito T, Suzuki H (2010) Emergence of H274Y oseltamivir-resistant A (H1N1) influenza viruses in Japan during the 2008–2009 season. J Clin Virol 47:23–28PubMedCrossRef Baranovich T, Saito R, Suzuki Y, Zaraket H, Dapat C, Caperig-Dapat I, Oguma T, Shabana II, Saito T, Suzuki H (2010) Emergence of H274Y oseltamivir-resistant A (H1N1) influenza viruses in Japan during the 2008–2009 season. J Clin Virol 47:23–28PubMedCrossRef
11.
go back to reference Eshaghi A, Bolotin S, Burton L, Low DE, Mazzulli T, Drews SJ (2009) Genetic microheterogeneity of emerging H275Y influenza virus A(H1N1) in Toronto, Ontario, Canada from the 2007–2008 respiratory season. J Clin Virol 45:142–145PubMedCrossRef Eshaghi A, Bolotin S, Burton L, Low DE, Mazzulli T, Drews SJ (2009) Genetic microheterogeneity of emerging H275Y influenza virus A(H1N1) in Toronto, Ontario, Canada from the 2007–2008 respiratory season. J Clin Virol 45:142–145PubMedCrossRef
12.
go back to reference Dharan NJ, Gubareva LV, Meyer JJ, Okomo-Adhiambo M, McClinton RC, Marshall SA, St George K, Epperson S, Brammer L, Klimov AI, Bresee JS, Fry AM (2009) Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA 301:1034–1041PubMedCrossRef Dharan NJ, Gubareva LV, Meyer JJ, Okomo-Adhiambo M, McClinton RC, Marshall SA, St George K, Epperson S, Brammer L, Klimov AI, Bresee JS, Fry AM (2009) Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA 301:1034–1041PubMedCrossRef
13.
go back to reference Meijer A, Lackenby A, Hungnes O, Lina B, van-der-Werf S, Schweiger B, Opp M, Paget J, van-de-Kassteele J, Hay A, Zambon M (2009) Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007–08 season. Emerg Infect Dis 15:552–560PubMed Meijer A, Lackenby A, Hungnes O, Lina B, van-der-Werf S, Schweiger B, Opp M, Paget J, van-de-Kassteele J, Hay A, Zambon M (2009) Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007–08 season. Emerg Infect Dis 15:552–560PubMed
14.
go back to reference de Jong MD, Tran TT, Truong HK, Vo MH, Smith GJ, Nguyen VC, Bach VC, Phan TQ, Do QH, Guan Y, Peiris JS, Tran TH, Farrar J (2005) Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med 353:2667–2672PubMedCrossRef de Jong MD, Tran TT, Truong HK, Vo MH, Smith GJ, Nguyen VC, Bach VC, Phan TQ, Do QH, Guan Y, Peiris JS, Tran TH, Farrar J (2005) Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med 353:2667–2672PubMedCrossRef
15.
go back to reference Yi H, Lee JY, Hong EH, Kim MS, Kwon D, Choi JH, Choi WY, Kim KS, Lee JK, Oh HB, Kang C (2010) Oseltamivir-resistant pandemic (H1N1) 2009 virus, South Korea. Emerg Infect Dis 16:1938–1942PubMedCrossRef Yi H, Lee JY, Hong EH, Kim MS, Kwon D, Choi JH, Choi WY, Kim KS, Lee JK, Oh HB, Kang C (2010) Oseltamivir-resistant pandemic (H1N1) 2009 virus, South Korea. Emerg Infect Dis 16:1938–1942PubMedCrossRef
16.
go back to reference Yang JR, Huang YP, Lin YC, Su CH, Kuo CY, Hsu LC, Wu HS, Liu MT (2010) Early findings of oseltamivir-resistant pandemic (H1N1) 2009 influenza A viruses in Taiwan. Antiviral Res 88:256–262PubMedCrossRef Yang JR, Huang YP, Lin YC, Su CH, Kuo CY, Hsu LC, Wu HS, Liu MT (2010) Early findings of oseltamivir-resistant pandemic (H1N1) 2009 influenza A viruses in Taiwan. Antiviral Res 88:256–262PubMedCrossRef
17.
go back to reference Meijer A, Jonges M, van Beek P, Swaan CM, Osterhaus AD, Daniels RS, Hurt AC, Koopmans MP (2012) Oseltamivir-resistant influenza A(H1N1)pdm09 virus in Dutch travellers returning from Spain, August 2012. Euro Surveill 17:20266PubMed Meijer A, Jonges M, van Beek P, Swaan CM, Osterhaus AD, Daniels RS, Hurt AC, Koopmans MP (2012) Oseltamivir-resistant influenza A(H1N1)pdm09 virus in Dutch travellers returning from Spain, August 2012. Euro Surveill 17:20266PubMed
18.
go back to reference Storms AD, Gubareva LV, Su S, Wheeling JT, Okomo-Adhiambo M, Pan CY, Reisdorf E, St George K, Myers R, Wotton JT, Robinson S, Leader B, Thompson M, Shannon M, Klimov A, Fry AM (2012) Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010–11. Emerg Infect Dis 18:308–311PubMedCrossRef Storms AD, Gubareva LV, Su S, Wheeling JT, Okomo-Adhiambo M, Pan CY, Reisdorf E, St George K, Myers R, Wotton JT, Robinson S, Leader B, Thompson M, Shannon M, Klimov A, Fry AM (2012) Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010–11. Emerg Infect Dis 18:308–311PubMedCrossRef
19.
go back to reference Choi WY, Kim S, Lee N, Kwon M, Yang I, Kim MJ, Cheong SG, Kwon D, Lee JY, Oh HB, Kang C (2009) Amantadine-resistant influenza A viruses isolated in South Korea from 2003 to 2009. Antiviral Res 84:199–202PubMedCrossRef Choi WY, Kim S, Lee N, Kwon M, Yang I, Kim MJ, Cheong SG, Kwon D, Lee JY, Oh HB, Kang C (2009) Amantadine-resistant influenza A viruses isolated in South Korea from 2003 to 2009. Antiviral Res 84:199–202PubMedCrossRef
20.
go back to reference Cho HG, Choi JH, Kim WH, Hong HK, Yoon MH, Jho EH, Kang C, Lim YH (2013) High prevalence of amantadine-resistant influenza A virus isolated in Gyeonggi Province, South Korea, during 2005–2010. Arch Virol 158:241–245PubMedCrossRef Cho HG, Choi JH, Kim WH, Hong HK, Yoon MH, Jho EH, Kang C, Lim YH (2013) High prevalence of amantadine-resistant influenza A virus isolated in Gyeonggi Province, South Korea, during 2005–2010. Arch Virol 158:241–245PubMedCrossRef
21.
go back to reference Deyde VM, Sheu TG, Trujillo AA, Okomo-Adhiambo M, Garten R, Klimov AI, Gubareva LV (2010) Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing. Antimicrob Agents Chemother 54:1102–1110PubMedCrossRef Deyde VM, Sheu TG, Trujillo AA, Okomo-Adhiambo M, Garten R, Klimov AI, Gubareva LV (2010) Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing. Antimicrob Agents Chemother 54:1102–1110PubMedCrossRef
22.
go back to reference Hatakeyama S, Sugaya N, Ito M, Yamazaki M, Ichikawa M, Kimura K, Kiso M, Shimizu H, Kawakami C, Koike K, Mitamura K, Kawaoka Y (2007) Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. JAMA 297:1435–1442PubMedCrossRef Hatakeyama S, Sugaya N, Ito M, Yamazaki M, Ichikawa M, Kimura K, Kiso M, Shimizu H, Kawakami C, Koike K, Mitamura K, Kawaoka Y (2007) Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. JAMA 297:1435–1442PubMedCrossRef
23.
go back to reference Monto AS, McKimm-Breschkin JL, Macken C, Hampson AW, Hay A, Klimov A, Tashiro M, Webster RG, Aymard M, Hayden FG, Zambon M (2006) Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother 50:2395–2402PubMedCrossRef Monto AS, McKimm-Breschkin JL, Macken C, Hampson AW, Hay A, Klimov A, Tashiro M, Webster RG, Aymard M, Hayden FG, Zambon M (2006) Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother 50:2395–2402PubMedCrossRef
24.
go back to reference Ko JH, Kim JH, Kang JH, Eun BW, Kim KH, Hong JY, Oh SH (2012) Characteristics of hospitalized children with 2009 pandemic influenza A (H1N1): a multicenter study in Korea. J Korean Med Sci 27:408–415PubMedCrossRef Ko JH, Kim JH, Kang JH, Eun BW, Kim KH, Hong JY, Oh SH (2012) Characteristics of hospitalized children with 2009 pandemic influenza A (H1N1): a multicenter study in Korea. J Korean Med Sci 27:408–415PubMedCrossRef
25.
go back to reference Shin SY, Kang C, Gwack J, Kim JH, Kim HS, Kang YA, Lee HG, Kim JS, Lee JK, Kim SH (2011) Drug-resistant pandemic (H1N1) 2009, South Korea. Emerg Infect Dis 17:702–704PubMedCrossRef Shin SY, Kang C, Gwack J, Kim JH, Kim HS, Kang YA, Lee HG, Kim JS, Lee JK, Kim SH (2011) Drug-resistant pandemic (H1N1) 2009, South Korea. Emerg Infect Dis 17:702–704PubMedCrossRef
26.
go back to reference Hurt AC, Hardie K, Wilson NJ, Deng YM, Osbourn M, Leang SK, Lee RT, Iannello P, Gehrig N, Shaw R, Wark P, Caldwell N, Givney RC, Xue L, Maurer-Stroh S, Dwyer DE, Wang B, Smith DW, Levy A, Booy R, Dixit R, Merritt T, Kelso A, Dalton C, Durrheim D, Barr IG (2012) Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia. J Infect Dis 206:148–157PubMedCrossRef Hurt AC, Hardie K, Wilson NJ, Deng YM, Osbourn M, Leang SK, Lee RT, Iannello P, Gehrig N, Shaw R, Wark P, Caldwell N, Givney RC, Xue L, Maurer-Stroh S, Dwyer DE, Wang B, Smith DW, Levy A, Booy R, Dixit R, Merritt T, Kelso A, Dalton C, Durrheim D, Barr IG (2012) Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia. J Infect Dis 206:148–157PubMedCrossRef
Metadata
Title
Oseltamivir-resistant influenza viruses isolated in South Korea from 2005 to 2010
Authors
Han-Gil Cho
Jang-Hoon Choi
Hyun-Kyung Lee
Su-Kyoung Mun
Jong-Bok Lee
Eek-Hoon Jho
Chun Kang
Young-Hee Lim
Publication date
01-11-2013
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 11/2013
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-013-1734-3

Other articles of this Issue 11/2013

Archives of Virology 11/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.